Breast Cancer Outreach Among Primary Care Patients

NCT05089903 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24680

Last updated 2022-06-27

No results posted yet for this study

Summary

This project aims to evaluate different approaches to increase breast cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, the investigators will evaluate different approaches to increase completion of screening among eligible patients, including ordering mammograms in bulk prior to outreach, sending personalized text reminders, and endorsing of the communication by the primary care provider.

Conditions

Interventions

BEHAVIORAL

Bulk Order

A mammogram order will be placed using bulk order technology in the EHR in advance of outreach for all patients.

BEHAVIORAL

Texting

In addition to outreach, patients will receive text messaging with information regarding the importance of screening, how to schedule a mammogram, and locations available for mammography.

BEHAVIORAL

Clinician Endorsement

Outreach informing patients that they are overdue for a mammogram will be signed by the patient's primary care provider.

BEHAVIORAL

No Bulk Order

The outreach will ask patients to contact their PCP's office in order to have a mammogram order placed on their behalf.

BEHAVIORAL

Standard Endorsement

Patient's will receive outreach from the practice informing them that they are overdue for a mammogram.

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Shivan Mehta, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-25
Primary Completion
2022-01-25
Completion
2022-04-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05089903 on ClinicalTrials.gov